Exposure of the A53T-α-synuclein mouse model of synucleinopathy to a brain-penetrant inhibitor of glucocerebrosidase (CBE) exacerbated the animals’ fine motor deficits and decreased their hippocampal memory function. This evidence concerns the gene SNCA and synucleinopathy.